Skip to main content
Erschienen in: International Journal of Hematology 3/2016

04.05.2016 | Case Report

Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature

verfasst von: Takuro Kuriyama, Noriaki Kawano, Kiyoshi Yamashita, Ikuo Kikuchi

Erschienen in: International Journal of Hematology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Primary bone lymphomas comprise <1 % of all malignant lymphomas, and there have been only a limited number of reports on primary adult T-cell leukemia/lymphoma (ATLL) of bone. Here, we report two cases of primary ATLL of bone. The first case was a 41-year-old woman with multiple bone tumors. She was diagnosed with ATLL of the skull through biopsy and treated with chemotherapy. Although the bone lesions showed transient improvement, the subsequent central nervous system (CNS) invasion of ATLL occurred and she died 7 months after diagnosis. The second case was a 65-year-old man with right coxodynia. He was diagnosed with ATLL through right femoral biopsy, and the lesion improved with chemotherapy. However, CNS invasion of ATLL developed during chemotherapy, and he died 10 months after diagnosis. Both the patients with primary ATLL of the bone reported here experienced CNS invasion. Thus, ATLL treatment should aim to prevent CNS invasion at an early stage.
Literatur
1.
Zurück zum Zitat Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.PubMed Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.PubMed
2.
Zurück zum Zitat Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9.CrossRefPubMedPubMedCentral Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Brit J Haematol. 1991;79:428–37.CrossRef Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Brit J Haematol. 1991;79:428–37.CrossRef
4.
Zurück zum Zitat Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458–64.CrossRefPubMed Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458–64.CrossRefPubMed
5.
Zurück zum Zitat Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27:453–9.CrossRefPubMedPubMedCentral Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27:453–9.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Desai S, Jambhekar NA, Soman CS, Advani SH. Primary lymphoma of bone: a clinicopathologic study of 25 cases reported over 10 years. J Surg Oncol. 1991;46:265–9.CrossRefPubMed Desai S, Jambhekar NA, Soman CS, Advani SH. Primary lymphoma of bone: a clinicopathologic study of 25 cases reported over 10 years. J Surg Oncol. 1991;46:265–9.CrossRefPubMed
7.
Zurück zum Zitat Gianelli U, Patriarca C, Moro A, Ponzoni M, Giardini R, Massimino M, et al. Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol. 2002;10:257–66.CrossRefPubMed Gianelli U, Patriarca C, Moro A, Ponzoni M, Giardini R, Massimino M, et al. Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol. 2002;10:257–66.CrossRefPubMed
8.
Zurück zum Zitat Matikas A, Briasoulis A, Tzannou I, Oikonomopoulou D, Bakiri M, Karmiris T, et al. Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center. Acta Haematol. 2013;130:291–6.CrossRefPubMed Matikas A, Briasoulis A, Tzannou I, Oikonomopoulou D, Bakiri M, Karmiris T, et al. Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center. Acta Haematol. 2013;130:291–6.CrossRefPubMed
9.
Zurück zum Zitat Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, et al. Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 1999;13:2094–8.CrossRefPubMed Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, et al. Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 1999;13:2094–8.CrossRefPubMed
10.
Zurück zum Zitat Takemoto S, Matsuoka M, Sakata K, Matsuzaki H, Akagi K, Yamaguchi K, et al. Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-I proviral DNA. Leukemia. 1996;10:333–7.PubMed Takemoto S, Matsuoka M, Sakata K, Matsuzaki H, Akagi K, Yamaguchi K, et al. Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-I proviral DNA. Leukemia. 1996;10:333–7.PubMed
11.
Zurück zum Zitat Hara T, Wakatsuki S, Ozaki S, Abe M, Kosaka M. Primary adult T-cell leukemia/lymphoma of bone. Int J Hematol. 2004;79:157–60.CrossRefPubMed Hara T, Wakatsuki S, Ozaki S, Abe M, Kosaka M. Primary adult T-cell leukemia/lymphoma of bone. Int J Hematol. 2004;79:157–60.CrossRefPubMed
12.
Zurück zum Zitat Martin A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, et al. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. Haematologica. 2008;93:1829–36.CrossRefPubMed Martin A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, et al. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. Haematologica. 2008;93:1829–36.CrossRefPubMed
13.
Zurück zum Zitat Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood. 2002;99:634–40.CrossRefPubMed Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood. 2002;99:634–40.CrossRefPubMed
14.
Zurück zum Zitat Tabata M, Takahashi H, Izumi T, Komatsu N, Tsunoda J, Yoshida M, et al. Adult T cell leukemia lymphoma (ATL) localized in the right tibial bone. Leuk Lymphoma. 1999;35:189–92.CrossRefPubMed Tabata M, Takahashi H, Izumi T, Komatsu N, Tsunoda J, Yoshida M, et al. Adult T cell leukemia lymphoma (ATL) localized in the right tibial bone. Leuk Lymphoma. 1999;35:189–92.CrossRefPubMed
15.
Zurück zum Zitat Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study 9303. Brit J Haematol. 2001;113:375–82.CrossRef Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study 9303. Brit J Haematol. 2001;113:375–82.CrossRef
16.
Zurück zum Zitat Govi S, Christie D, Messina C, Bruno Ventre M, Gracia Medina EA, Porter D, et al. The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone. Ann Oncol. 2014;25:176–81.CrossRefPubMed Govi S, Christie D, Messina C, Bruno Ventre M, Gracia Medina EA, Porter D, et al. The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone. Ann Oncol. 2014;25:176–81.CrossRefPubMed
17.
Zurück zum Zitat Messina C, Ferreri A, Govi S, Bruno-Ventre M, Gracia Medina EA, Porter D, et al. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study). Brit J Haematol. 2014;164:834–40.CrossRef Messina C, Ferreri A, Govi S, Bruno-Ventre M, Gracia Medina EA, Porter D, et al. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study). Brit J Haematol. 2014;164:834–40.CrossRef
18.
Zurück zum Zitat Fukushima T, Taguchi J, Moriuchi Y, Yoshida S, Itonaga H, Ando K, et al. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience. Int J Hematol. 2011;94:390–4.CrossRefPubMed Fukushima T, Taguchi J, Moriuchi Y, Yoshida S, Itonaga H, Ando K, et al. Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience. Int J Hematol. 2011;94:390–4.CrossRefPubMed
Metadaten
Titel
Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature
verfasst von
Takuro Kuriyama
Noriaki Kawano
Kiyoshi Yamashita
Ikuo Kikuchi
Publikationsdatum
04.05.2016
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 3/2016
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2015-1

Weitere Artikel der Ausgabe 3/2016

International Journal of Hematology 3/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.